Comparison of cardiac magnetic resonance imaging and positron emission tomography for the diagnosis and localization of coronary artery disease
© Morton et al; licensee BioMed Central Ltd. 2011
Published: 2 February 2011
Compare the diagnostic performance of Cardiac Magnetic Resonance (CMR) myocardial perfusion imaging against Positron Emission Tomography (PET) in coronary artery disease (CAD).
PET is regarded as the non-invasive reference-standard for assessment of myocardial perfusion. However, there are few data comparing the performance of CMR against PET perfusion imaging, particularly in patients with a high prevalence of CAD. In addition, novel MR techniques, e.g. based on kt acceleration techniques, allow perfusion imaging with improved spatial resolution.
22 patients with known or suspected CAD underwent both 13N-Ammonia PET and CMR adenosine stress and rest perfusion imaging prior to diagnostic coronary X-ray angiography (CXA). CMR perfusion imaging was performed at 1.5T with a kt-accelerated steady-state free-precession sequence.
Data analysis was blind. A significant coronary artery stenosis was defined as at least 70% diameter reduction or a fractional flow reserve <0.8. Sensitivity and specificity for PET and CMR versus invasive angiography were calculated. Localization of ischaemia was assessed in patients with CAD by classifying territories that were ischaemic on imaging as either supplied by, or as remote from, a stenotic artery.
Previous percutaneous coronary intervention
For the detection of CAD PET sensitivity was 83% (95% CI 58-96%) and specificity 75% (95% CI 22-99%). CMR sensitivity was 82% (95% CI 56-95%) and specificity 75% (95% CI 22-99%). In the 18 patients with CAD there was detectable ischaemia in 79% of the coronary artery territories supplied by significantly stenotic arteries with both PET and CMR. Ischaemia was also detected in 20% of remote territories with PET and 17% with CMR. 50% (n=3) of the territories with remote ischaemia on PET imaging also had remote ischaemia on CMR imaging.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.